Free Trial
NASDAQ:TOI

Oncology Institute (TOI) Stock Price, News & Analysis

Oncology Institute logo
$3.14 +0.26 (+8.99%)
As of 03:35 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Oncology Institute Stock (NASDAQ:TOI)

Key Stats

Today's Range
$2.90
$3.50
50-Day Range
$0.61
$2.88
52-Week Range
$0.13
$3.48
Volume
1.77 million shs
Average Volume
787,712 shs
Market Capitalization
$237.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Oncology Institute Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

TOI MarketRank™: 

Oncology Institute scored higher than 5% of companies evaluated by MarketBeat, and ranked 905th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Oncology Institute.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Oncology Institute is -4.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Oncology Institute is -4.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Oncology Institute has a P/B Ratio of 4.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Oncology Institute's valuation and earnings.
  • Percentage of Shares Shorted

    3.97% of the float of Oncology Institute has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncology Institute has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncology Institute has recently increased by 17.27%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Oncology Institute does not currently pay a dividend.

  • Dividend Growth

    Oncology Institute does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.97% of the float of Oncology Institute has been sold short.
  • Short Interest Ratio / Days to Cover

    Oncology Institute has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Oncology Institute has recently increased by 17.27%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Oncology Institute this week, compared to 2 articles on an average week.
  • Search Interest

    7 people have searched for TOI on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Oncology Institute insiders have bought more of their company's stock than they have sold. Specifically, they have bought $127,148.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 8.50% of the stock of Oncology Institute is held by insiders.

  • Percentage Held by Institutions

    Only 36.86% of the stock of Oncology Institute is held by institutions.

  • Read more about Oncology Institute's insider trading history.
Receive TOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter.

TOI Stock News Headlines

Trump to redistribute trillions of dollars
This playbook is something my connections and I have been discussing in private ever since we met with Trump at Mar-a-Lago last year. And while Trump has never formally acknowledged this plan, if you connect the dots on the chaos he’s been sowing, it’s obvious.
Q4 2024 Oncology Institute Inc Earnings Call
See More Headlines

TOI Stock Analysis - Frequently Asked Questions

Oncology Institute's stock was trading at $0.3090 at the start of the year. Since then, TOI stock has increased by 974.1% and is now trading at $3.3190.
View the best growth stocks for 2025 here
.

The Oncology Institute, Inc. (NASDAQ:TOI) announced its quarterly earnings results on Monday, March, 24th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.06. The company earned $100.27 million during the quarter, compared to analysts' expectations of $109.15 million. Oncology Institute had a negative net margin of 17.63% and a negative trailing twelve-month return on equity of 186.83%.
Read the conference call transcript
.

Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncology Institute investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Arista Networks (ANET), Adobe (ADBE), AppLovin (APP) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
3/24/2025
Today
4/24/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
Healthcare
Current Symbol
NASDAQ:TOI
Fax
N/A
Employees
660
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-83,070,000.00
Pretax Margin
-18.62%

Debt

Sales & Book Value

Annual Sales
$393.41 million
Price / Cash Flow
N/A
Book Value
$0.77 per share
Price / Book
3.74

Miscellaneous

Free Float
68,381,000
Market Cap
$217.61 million
Optionable
Not Optionable
Beta
0.22
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:TOI) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners